-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Immunocore Holdings plc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2023 to Q2 2024.
- Immunocore Holdings plc Operating Income (Loss) for the quarter ending June 30, 2024 was -$16M, a 16.4% decline year-over-year.
- Immunocore Holdings plc annual Operating Income (Loss) for 2023 was -$59.6M, a 15.4% decline from 2022.
- Immunocore Holdings plc annual Operating Income (Loss) for 2022 was -$51.7M, a 70.4% increase from 2021.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)